Aptorum Stock Price

-0.05 (-1.61%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aptorum Group Ltd APM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -1.61% 3.05 18:30:51
Open Price Low Price High Price Close Price Prev Close
3.14 3.10 3.1843 3.10 3.10
Bid Price Ask Price Spread News
3.05 3.18 0.13 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
349 72,958 $ 3.13 $ 228,370 948,855 1.16 - 14.23
Last Trade Time Type Quantity Stock Price Currency
18:21:21 30 $ 3.04 USD

Aptorum Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 103.74M 34.01M 8.35M $ 535.17k $ - -0.64 -6.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Aptorum News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.903.9053.02513.39507,809-0.85-21.79%
1 Month3.324.563.02513.74586,481-0.27-8.13%
3 Months2.614.942.313.68752,2240.4416.86%
6 Months1.9314.231.163.781,199,9621.1258.03%
1 Year5.8014.231.163.73629,147-2.75-47.41%
3 Years15.8033.281.163.87294,375-12.75-80.7%
5 Years15.8033.281.163.87294,375-12.75-80.7%

Aptorum Description

Aptorum Group Ltd is a pharmaceutical company. It is engaged in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. The pipeline of Aptorum is also enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through, e.g. systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The firm is also seeking therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.